Myriad Genetics, Inc (NASDAQ:MYGN) price closed lower on Tuesday, April 29, and dropping -4.00% below its previous close. A look at the daily price movement shows that the last close reads $7.50, with intraday deals fluctuated between $7.17 and $7.56. The company’s 5Y monthly beta
Myriad Genetics, Inc (NASDAQ:MYGN) price closed lower on Monday, April 07, and dropping -0.74% below its previous close. A look at the daily price movement shows that the last close reads $8.13, with intraday deals fluctuated between $7.81 and $8.63. The company’s 5Y monthly beta
Myriad Genetics, Inc (NASDAQ:MYGN) shares, rose in value on Friday, March 28, with the stock price down by -3.69% to the previous day’s close as strong demand from buyers drove the stock to $8.88. Actively observing the price movement in the last trading, the stock
Myriad Genetics, Inc (NASDAQ:MYGN) concluded the trading at $10.07 on Friday, March 14 with a rise of 3.81% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $9.70 and 5Y monthly beta
Myriad Genetics, Inc (NASDAQ:MYGN) traded at $9.60 at close of the session on Monday, March 10 and made a downward move of -5.70% on its previous day’s price. Myriad Genetics, Inc has a market cap of $876.57 million and is expected to release its quarterly
The trading price of Myriad Genetics, Inc (NASDAQ:MYGN) closed lower on Monday, March 03, and closing at $10.39, -3.17% lower than its previous close. In examining the 52-week price action we see that the stock hit a 52-week high of $29.30 and a 52-week low
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
